Menu

CME Corner

Active Programs

Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management

Interstitial lung disease (ILD) is a frequent complication of the autoimmune disorder systemic sclerosis (SSc). SSc-ILD remains a challenging condition to identify, treat, and manage. Early identification of ILD in patients with SSc is critical so that treatment can be initiated as soon as possible. However, utilization of optimal screening and diagnosis strategies is low among healthcare provider ...

  • Online Presentation Online Presentation
  • ACCME

Precision Medicine in Severe Asthma: The Importance of Phenotypes and Endotypes in Patient Evaluation

Severe asthma affects only 3-6% of the overall population of asthmatics, but accounts for nearly half of the annual expenditures among asthma patients. Advances in the understanding of the pathophysiology of severe asthma have led to the identification of specific asthma endotypes and phenotypes that may be used to better tailor therapy in the future. This activity will explore the value of determ ...

  • Online Presentation Online Presentation
  • ACCME

Precision Medicine in Severe Asthma: How Phenotypes and Endotypes Guide Treatment Decisions

Despite advances in understanding the drivers of severe asthma, rates of hospitalization and mortality due to asthma have not changed significantly in the last two decades. Its only recently as the medical community has become better at identifying specific asthma endotypes and phenotypes that weve seen the rise of unique therapies targeting specific disease pathways. This activity will break do ...

  • Online Presentation Online Presentation
  • ACCME

Decoding Interstitial Lung Disease: Identifying and Managing Progressive Phenotypes

Interstitial lung disease (ILD) comprises more than 130 distinct lung disorders. Some forms of ILD, including connective tissue disease-associated ILD (CTD-ILD), chronic hypersensitivity pneumonitis (CHP), and fibrosing types of ILD such as fibrotic nonspecific interstitial pneumonia (fNSIP), follow a particularly aggressive course. This activity will address the timely identification and treatmen ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Management of Severe Asthma in Patients with Type 2 Inflammation

This interactive case-based activity will examine factors contributing to severe asthma, the role of type 2 inflammation, and novel agents to manage severe asthma in patients with type 2 inflammation. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • AANP
  • AAPA
  • ACCME

Type 2 Inflammation in Asthma: Considerations for Targeted Therapy

This interactive case-based activity will examine treatment strategies for uncontrolled type 2 asthma. ...

  • Mobile + Online on RealCME
  • ACCME

Expired Programs

Comprehensive Care in COPD: Strategies for Nurse Practitioners (Program ID: 18012973)

This activity will examine COPD risk factors, strategies for the recognition and assessment of early symptoms, criteria for diagnosis, and the implementation of a comprehensive patient-centered approach to disease management. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Exploring the Role of Type 2 Inflammation in Uncontrolled Asthma

This interactive case-based activity will examine uncontrolled asthma and the role played by type 2 inflammation. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Identifying and Diagnosing Interstitial Lung Disease

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. This activity will examine strategies for identifying and accurately diagnosing ILD. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation
  • ACCME
Main Menu
EDITOR'S PICKS